☆ 4.7 Article

Heterogeneity of Treatment Effects ofHydrocortisone by Risk of Bronchopulmonary Dysplasia or DeathAmong Extremely Preterm Infants in the National Institute of Child Health andHumanDevelopment NeonatalResearchNetwork Trial A Secondary Analysis of a Randomized Clinical Trial

JAMA NETWORK OPEN (2023)

Related references

Note: Only part of the references are listed.

Article Medicine, General & Internal

Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia

K. L. Watterberg et al.

Summary: This trial found that hydrocortisone treatment starting on postnatal day 14 to 28 did not significantly improve the survival without moderate or severe bronchopulmonary dysplasia compared to placebo. The survival without moderate or severe neurodevelopmental impairment also did not differ significantly between the two groups.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Review Pediatrics

Interventions to Prevent Bronchopulmonary Dysplasia in Preterm Neonates An Umbrella Review of Systematic Reviews and Meta-analyses

Thangaraj Abiramalatha et al.

Summary: This study summarized and evaluated interventions proposed to decrease the risk of bronchopulmonary dysplasia (BPD) based on multiple systematic reviews. The findings indicate that delivery room continuous positive airway pressure, early selective surfactant administration, early hydrocortisone prophylaxis, inhaled corticosteroids, and volume-targeted ventilation may decrease the combined risk of BPD or mortality.

JAMA PEDIATRICS (2022)

Add to Collection

Article Pediatrics

Online clinical tool to estimate risk of bronchopulmonary dysplasia in extremely preterm infants

Rachel G. Greenberg et al.

Summary: This study aims to develop an online estimator that accurately predicts the severity of bronchopulmonary dysplasia (BPD) or death in preterm infants using readily-available demographic and clinical data. The results show that the respiratory support mode and birth weight can predict the occurrence and severity of BPD with reasonable accuracy over time. This online estimator can aid in clinical prognostication, future research, and quality improvement in BPD prevention.

ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2022)

Add to Collection

Article Medicine, General & Internal

Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia

K. L. Watterberg et al.

Summary: In this trial involving preterm infants, hydrocortisone treatment starting on postnatal day 14 to 28 did not result in substantially higher survival without moderate or severe bronchopulmonary dysplasia than placebo. Survival without moderate or severe neurodevelopmental impairment did not differ substantially between the two groups.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

Heterogeneity of Treatment Effects in an Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale After Stroke

David M. Kent et al.

Summary: Among patients aged 18 to 60 years with PFO-associated stroke, the risk reduction for recurrent stroke with device closure varied across groups classified by their probabilities that the stroke was causally related to the PFO. The application of scoring systems can guide individualized decision-making in the treatment of PFO-associated strokes.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Pediatrics

Should Vitamin A Injections to Prevent Bronchopulmonary Dysplasia or Death Be Reserved for High-Risk Infants? Reanalysis of the National Institute of Child Health and Human Development Neonatal Research Network Randomized Trial

Matthew A. Rysavy et al.

Summary: Contrary to expectations, the study found that the effect of vitamin A therapy on reducing the risk of bronchopulmonary dysplasia or death was greater for lower risk infants than higher risk infants.

JOURNAL OF PEDIATRICS (2021)

Add to Collection

Review Pediatrics

Assessment of Postnatal Corticosteroids for the Prevention of Bronchopulmonary Dysplasia in Preterm Neonates A Systematic Review and Network Meta-analysis

Viraraghavan Vadakkencherry Ramaswamy et al.

Summary: The study evaluated 14 corticosteroid regimens for preventing bronchopulmonary dysplasia in preterm neonates, finding that early-initiated dexamethasone and fluticasone may reduce the risk of BPD or mortality.

JAMA PEDIATRICS (2021)

Add to Collection

Review Medicine, General & Internal

Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants

Lex W. Doyle et al.

Summary: Early systemic postnatal corticosteroid treatment can prevent bronchopulmonary dysplasia (BPD) and the combined outcome of mortality or BPD, but it may increase risks of gastrointestinal perforation, cerebral palsy, and the combined outcome of mortality or cerebral palsy. Most beneficial and harmful effects are related to early treatment with dexamethasone rather than hydrocortisone, although hydrocortisone may help prevent mortality. Long-term follow-up into late childhood is crucial for assessing the impact of early corticosteroid treatment on higher-order neurological functions. Further research on early corticosteroids, especially hydrocortisone, should prioritize longer-term survival free of neurodevelopmental disability as the primary outcome.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)

Add to Collection

Article Medicine, General & Internal

The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration

David M. Kent et al.

ANNALS OF INTERNAL MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement

David M. Kent et al.

ANNALS OF INTERNAL MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation A Randomized Clinical Trial

Wes Onland et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Add to Collection

Article Critical Care Medicine

The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants An Evidence-based Approach

Erik A. Jensen et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)

Add to Collection

Article Pediatrics

Effect of Prophylaxis for Early Adrenal Insufficiency Using Low-Dose Hydrocortisone in Very Preterm Infants: An Individual Patient Data Meta-Analysis

Michele L. Shaffer et al.

JOURNAL OF PEDIATRICS (2019)

Add to Collection

Article Pediatrics

Race Effects of Inhaled Nitric Oxide in Preterm Infants: An Individual Participant Data Meta-Analysis

Lisa M. Askie et al.

JOURNAL OF PEDIATRICS (2018)

Add to Collection

Article Medicine, General & Internal

Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial

Olivier Baud et al.

LANCET (2016)

Add to Collection

Article Respiratory System

Structural and Functional Lung Impairment in Adult Survivors of Bronchopulmonary Dysplasia

Steven Caskey et al.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2016)

Add to Collection

Article Medicine, General & Internal

Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012

Barbara J. Stoll et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)

Add to Collection

Article Pediatrics

An Update on the Impact of Postnatal Systemic Corticosteroids on Mortality and Cerebral Palsy in Preterm Infants: Effect Modification by Risk of Bronchopulmonary Dysplasia

Lex W. Doyle et al.

JOURNAL OF PEDIATRICS (2014)

Add to Collection

Article Critical Care Medicine

Prediction of Bronchopulmonary Dysplasia by Postnatal Age in Extremely Premature Infants

Matthew M. Laughon et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)

Add to Collection

Article Pediatrics

Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia

RA Ehrenkranz et al.

PEDIATRICS (2005)

Add to Collection

Article Pediatrics

Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: Effect modification by risk for chronic lung disease

LW Doyle et al.

PEDIATRICS (2005)

Add to Collection

Article Pediatrics

Impact of a physiologic definition on bronchopulmonary dysplasia rates

MC Walsh et al.

PEDIATRICS (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.